Umbilical Cord Blood Unit
Phase 2Small molecule
Umbilical Cord Blood Unit is one of 57 small molecule programs targeting Blood Transfusion. It is currently in Phase 2.
2
Indications
2
Total Trials
0
Active Trials
56
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
508 competitors in Leukemia
#DrugCompanyPhaseTrials
1Cytosar
TevaPhase 3
Trexall
Alnylam PharmaceuticalsPhase 3
Fludara
SanofiPhase 3
Rituxan
RochePhase 3
Fludara
SanofiPhase 3
Vepesid
AAvyxa
Phase 3
Oncovin
Eli LillyPhase 3
Decadron
AAspen Global Incorporated
Phase 3
Leukine
SanofiPhase 3
Cellcept
RochePhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Leukemia1 trial
Blood Transfusion1 trial
Umbilical Cord Blood Transfusion in Progeria Syndrome
Completed·—·Phase 1/2·NCT03871972·2 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Umbilical Cord Blood Unit. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details